This is a routine insider sale by a director, likely for personal liquidity or tax planning. The small size relative to market cap and the fact that it involves option exercise and RSU vesting suggests no negative signal about the company's outlook. Monitor for any subsequent Form 4 filings to confirm the sale was executed.
Price Chart
Executive Summary
Director Karin Eastham filed a Form 144 notice of intent to sell 14,850 shares of Veracyte common stock, with an estimated aggregate market value of approximately $715,770. The shares to be sold include 10,000 shares acquired through exercise of stock options and 4,850 shares from restricted stock units. The proposed sale is scheduled for October 27, 2026, on Nasdaq.
Key Facts
- Insider: Karin Eastham, Director of Veracyte, Inc.
- Proposed sale of 14,850 shares of common stock
- Estimated aggregate market value: $715,770
- Shares to be sold include 10,000 from stock option exercise and 4,850 from restricted stock units
- Proposed sale date: October 27, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Approximately $715,770 based on 14,850 shares at an estimated price; relative to Veracyte's $3.9B market cap, this represents about 0.018% of shares outstanding, a very small fraction.
Risk Factors
- Form 144 is only an intent to sell; the sale may not be completed
- Insider selling, even small, can sometimes be misinterpreted by the market
- No additional context on the company's recent financial performance or guidance was provided in the filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010439 |
| Document: 0001950047-26-010439-index.html | 0001950047-26-010439 |
| Document: 0001950047-26-010439.txt | 0001950047-26-010439 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | Institutional Cluster | $50.06 | awaiting T+20 | awaiting T+20 | $50.01 (−0.10%) |
Oct 28, 2026 4d ago | Insider Cluster | $52.17 | awaiting T+20 | awaiting T+20 | $50.01 (−4.14%) |
Oct 28, 2026 4d ago | Insider Cluster | $52.17 | awaiting T+20 | awaiting T+20 | $50.01 (−4.14%) |
Oct 27, 2026 5d ago | 144 | $50.31 | awaiting T+20 | awaiting T+20 | $50.01 (−0.60%) |
Oct 27, 2026 5d ago | 144 | $50.31 | awaiting T+20 | awaiting T+20 | $50.01 (−0.60%) |
Sep 22, 2026 5w ago | Insider Cluster | $43.82 $46.22 | ▲ +5.48% | ▲ +4.79% | $50.01 (+14.13%) |
Sep 14, 2026 6w ago | Press Release | $40.14 $43.11 | ▲ +7.40% | ▲ +4.68% | $50.01 (+24.59%) |
Sep 4, 2026 8w ago | Insider Cluster | $42.45 $44.65 | ▲ +5.18% | ▲ +3.47% | $50.01 (+17.81%) |
Jun 18, 2026 19w ago | 144 | $53.19 $59.13 | ▲ +11.17% | ▲ +11.32% | $50.01 (−5.98%) |
Jun 11, 2026 20w ago | Institutional Cluster | $47.33 $56.97 | ▲ +20.37% | ▲ +18.59% | $50.01 (+5.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers